Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China

NCT: NCT03736226 · ACTIVE_NOT_RECRUITING

NCT IDNCT03736226
StatusACTIVE_NOT_RECRUITING
Start Date2019-07-30
Completion2028-03-31

Brief Summary

A prospective, observational, single-arm, open-label, multicenter, post-approval study. To compile real-world clinical outcomes data for the SYNERGYTM MONORAILTM Everolimus-Eluting Platinum Chromium Coronary Stent System (SYNERGYTM Stent System) in real-world clinical practice in China.

Frequently Asked Questions

What is A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China?

A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China is a clinical trial registered under NCT03736226. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03736226?

The current status of NCT03736226 (A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China) is: ACTIVE_NOT_RECRUITING.

When did A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China start?

A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China started on 2019-07-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑